ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
온카스파 시장 규모는 향후 몇 년 동안 강력한 성장을 보일 것으로 예상됩니다. 예측 기간의 성장은 생명 공학 및 의약품 개발의 발전, 제품 승인 건수 증가, 종양학 치료 옵션의 확대, 유리한 규제 승인 및 적응증 확대, 의료에 대한 투자 증가에 기인할 수 있습니다. 예측 기간의 주요 동향으로는 페길화 제품, 맞춤형 의약품 및 표적 치료법의 채택 증가, 아스파라기나제 제형의 기술 발전, 바이오시밀러 대체품에 대한 수요 증가 등이 있습니다.
암의 유병률 증가는 온카스파 시장 성장을 촉진할 것으로 예상됩니다. 암은 주변 조직으로 침투하고 전신으로 확산될 수 있는 비정상적인 세포 증식으로 특징지어지는 질병의 그룹입니다. 유전적 변이는 정상적인 세포 과정을 방해하여 종양 형성과 전이에 기여합니다. 온카스파(아스파라기나제)는 백혈병 세포의 성장에 필수적인 아미노산인 아스파라긴을 표적화하고 고갈시켜 그 증식을 방해합니다. 이는 다른 형태의 아스파라기나제 치료를 견딜 수 없는 환자의 백혈병 재발 가능성을 줄이고 생존율을 개선합니다. 미국 암 학회에 따르면, 2022년 1월 미국에서 약 190만 건의 새로운 암 사례와 60만 9,360건의 암 관련 사망이 예상되며, 주요 암 유형으로는 폐암, 전립선암, 대장암, 유방암 등이 있습니다. 전 세계적으로 암 발병 건수가 증가하면서 온카스파 시장도 성장하고 있습니다.
의료 연구 및 개발에 대한 정부의 이니셔티브는 온카스파 시장 성장을 촉진하고 있습니다. 정부의 조치, 프로그램, 정책 및 자금 지원 노력은 건강 문제를 해결하고 의학 연구를 발전시키는 데 목적이 있습니다. 예를 들어, 2022년에 영국 정부는 의료 연구, 진단 및 치료를 지원하기 위해 2억 6,000만 파운드(2억 7,065만 달러)를, 영국 생명 과학 산업을 활성화하기 위해 6,000만 파운드(6,360만 달러)를 지원하기로 약속했습니다. 이러한 이니셔티브는 의료 생태계를 개선하고 온카스파와 같은 치료제의 이용 가능성을 높임으로써 시장 성장을 촉진하고 있습니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 바이오의약품 시장에서의 제품 특성
분자 유형
투여경로(ROA)
작용기전(MOA)
안전성과 유효성
제4장 시장 동향과 전략
제5장 시장 - 거시경제 시나리오 금리, 인플레이션, 지정학, 신형 코로나 바이러스 감염, 경기 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제6장 세계의 성장 분석과 전략 분석 프레임워크
세계의 온카스파 : PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
최종 이용 산업의 분석
세계의 온카스파 시장 : 성장률 분석
세계의 온카스파 시장 실적 : 규모와 성장(2019-2024년)
세계의 온카스파 시장 예측 : 규모와 성장(2024-2029년, 2034년)
세계의 온카스파 : 전체 시장 규모(TAM)
제7장 세계 시장의 가격 분석과 예측
제8장 시장 세분화
세계의 온카스파 시장 : 제품 유형별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
동결건조 온카스파
액체 온카스파
세계의 온카스파 시장 : 유통 채널별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
병원
전문 클리닉
온라인 약국
기타
세계의 온카스파 시장 : 용도별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
급성 림프성 백혈병
림프성 림프종
기타
제9장 임상적응증 세계 시장 역학
약제의 부작용
임상적응증의 발병률과 유병률
제10장 지역별, 국가별 분석
세계의 온카스파 시장 : 지역별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
세계의 온카스파 시장 : 국가별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
제11장 아시아태평양 시장
제12장 중국 시장
제13장 인도 시장
제14장 일본 시장
제15장 호주 시장
제16장 한국 시장
제17장 서유럽 시장
제18장 영국 시장
제19장 독일 시장
제20장 프랑스 시장
제21장 동유럽 시장
제22장 북미 시장
제23장 미국 시장
제24장 캐나다 시장
제25장 남미 시장
제26장 중동 시장
제27장 아프리카 시장
제28장 경쟁 구도와 기업 프로파일
온카스파 시장 : 경쟁 구도
온카스파 시장 : 기업 프로파일
Servier Pharmaceuticals LLC
제29장 세계 시장 : 파이프라인 분석
제30장 세계 시장 경쟁 벤치마킹과 대시보드
제31장 주요 인수합병(M&A)
제32장 최근 시장 동향
제33장 시장의 잠재력이 높은 국가, 전략
온카스파 시장(2029년) : 새로운 기회를 제공하는 국가
온카스파 시장(2029년) : 새로운 기회를 제공하는 부문
온카스파 시장(2029년) : 성장 전략
시장 동향에 의한 전략
경쟁 전략
제34장 부록
HBR
영문 목차
영문목차
Oncaspar (pegaspargase) is a PEGylated form of the enzyme asparaginase, primarily used in chemotherapy to treat acute lymphoblastic leukemia (ALL). It works by depleting asparagine, an amino acid that is crucial for the growth of certain cancer cells, thereby inhibiting their ability to multiply and survive. Oncaspar is often preferred when other asparaginase treatments are either ineffective or poorly tolerated.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The key product types of oncaspar are lyophilized Oncaspar and liquid Oncaspar. Lyophilized Oncaspar is a freeze-dried powder that, when reconstituted with a liquid, retains its stability, making it easier to store and transport. It is distributed through various channels, including hospitals, specialty clinics, and online pharmacies, for treating conditions such as acute lymphoblastic leukemia, lymphoblastic lymphoma, and others.
The oncaspar market research report is one of a series of new reports from The Business Research Company that provides oncaspar market statistics, including the oncaspar industry global market size, regional shares, competitors with the oncaspar market share, detailed oncaspar market segments, market trends, and opportunities, and any further data you may need to thrive in the oncaspar industry. This oncaspar market research reports deliver a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.
The oncaspar market size is expected to see strong growth in the next few years. It will grow to $244.4 million in 2029 at a compound annual growth rate (CAGR) of 10%. The growth in the forecast period can be attributed to advances in biotechnology and drug development, an increasing number of product approvals, expansion of treatment options in oncology, favorable regulatory approvals and expanded indications, and increasing investments in healthcare. Major trends in the forecast period include the rising adoption of pegylated products, personalized medicine and targeted therapies, technological advancements in asparaginase formulation, and rising demand for biosimilar alternatives.
The increasing prevalence of cancer is expected to drive the growth of the oncaspar market. Cancer is a group of diseases characterized by abnormal cell growth that can invade nearby tissues and spread throughout the body. Genetic mutations disrupt normal cell processes, contributing to tumor formation and metastasis. Oncaspar (pegaspargase) works by targeting and depleting asparagine, an amino acid crucial for the growth of leukemia cells, thereby hindering their proliferation. This reduces the likelihood of leukemia recurrence and improves survival in patients who cannot tolerate other forms of asparaginase therapy. According to the American Cancer Society, in January 2022, approximately 1.9 million new cancer cases and 609,360 cancer-related deaths were expected in the U.S., with major cancer types including lung, prostate, colorectal, and breast cancers. The rising number of cancer cases globally is propelling growth in the oncaspar market.
Government initiatives for healthcare research and development are driving the growth of the oncaspar market. Government actions, programs, policies, and funding efforts are aimed at addressing health issues and advancing medical research. For instance, in 2022, the UK government committed £260 million (US $270.65 million) in funding to support healthcare research, diagnostics, and treatment, alongside £60 million (US $63.60 million) to boost life sciences manufacturing in the UK. These initiatives are enhancing the healthcare ecosystem and driving the availability of treatments such as oncaspar, thus fostering market growth.
A key trend in the oncaspar market is the development of advanced pediatric formulations of pegaspargase to improve the treatment process for acute lymphoblastic leukemia (ALL). The pediatric formulation is specifically designed for children with ALL, helping to reduce the risk of relapse and offering effective treatment, particularly for those allergic to native asparaginase. In March 2024, Gennova Biopharma launched a pediatric pack size of pegaspargase under the brand name HAMSYL Junior in India. The 1500 IU pack size is designed for precise dosing in children, reducing wastage and ensuring effective treatment while maintaining the same API strength as the adult version. This development is a significant advancement in pediatric oncology, making Oncaspar more accessible and affordable for young patients in India.
Key player operating in the oncaspar market is Servier Pharmaceuticals LLC.
North America was the largest region in the oncaspar market in 2024. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in oncaspar report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the oncaspar market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The oncaspar market consists of sales of reconstituted oncaspar, prefilled syringe oncaspar, and vial oncaspar. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Oncaspar Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on oncaspar market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 10 geographies.
Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 3-4 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for oncaspar ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The oncaspar market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:1) By Product Type: Lyophilized Oncaspar; Liquid Oncaspar
2) By Distribution Channel: Hospitals; Specialty Clinics; Online Pharmacies; Other Distribution Channels
3) By Application: Acute Lymphoblastic Leukemia; Lymphoblastic Lymphoma; Other Applications
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Oncaspar Market Characteristics
3. Oncaspar Market Biologic Drug Characteristics
3.1. Molecule Type
3.2. Route Of Administration (ROA)
3.3. Mechanism Of Action (MOA)
3.4. Safety And Efficacy
4. Oncaspar Market Trends And Strategies
5. Oncaspar Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market
6. Global Oncaspar Growth Analysis And Strategic Analysis Framework
6.1. Global Oncaspar PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
6.2. Analysis Of End Use Industries
6.3. Global Oncaspar Market Growth Rate Analysis
6.4. Global Oncaspar Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
6.5. Global Oncaspar Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
6.6. Global Oncaspar Total Addressable Market (TAM)
7. Global Oncaspar Market Pricing Analysis & Forecasts
8. Oncaspar Market Segmentation
8.1. Global Oncaspar Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Lyophilized Oncaspar
Liquid Oncaspar
8.2. Global Oncaspar Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals
Specialty Clinics
Online Pharmacies
Other Distribution Channels
8.3. Global Oncaspar Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Acute Lymphoblastic Leukemia
Lymphoblastic Lymphoma
Other Applications
9. Global Oncaspar Market Epidemiology Of Clinical Indications
9.1. Drug Side Effects
9.2. Incidence And Prevalence of Clinical Indications
10. Oncaspar Market Regional And Country Analysis
10.1. Global Oncaspar Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. Global Oncaspar Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Asia-Pacific Oncaspar Market
11.1. Asia-Pacific Oncaspar Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
11.2. Asia-Pacific Oncaspar Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Asia-Pacific Oncaspar Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Asia-Pacific Oncaspar Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. China Oncaspar Market
12.1. China Oncaspar Market Overview
12.2. China Oncaspar Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
12.3. China Oncaspar Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
12.4. China Oncaspar Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
13. India Oncaspar Market
13.1. India Oncaspar Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. India Oncaspar Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. India Oncaspar Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. Japan Oncaspar Market
14.1. Japan Oncaspar Market Overview
14.2. Japan Oncaspar Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. Japan Oncaspar Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. Japan Oncaspar Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Australia Oncaspar Market
15.1. Australia Oncaspar Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.2. Australia Oncaspar Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Australia Oncaspar Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. South Korea Oncaspar Market
16.1. South Korea Oncaspar Market Overview
16.2. South Korea Oncaspar Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. South Korea Oncaspar Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.4. South Korea Oncaspar Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Western Europe Oncaspar Market
17.1. Western Europe Oncaspar Market Overview
17.2. Western Europe Oncaspar Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Western Europe Oncaspar Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.4. Western Europe Oncaspar Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. UK Oncaspar Market
18.1. UK Oncaspar Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. UK Oncaspar Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. UK Oncaspar Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Germany Oncaspar Market
19.1. Germany Oncaspar Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Germany Oncaspar Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Germany Oncaspar Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. France Oncaspar Market
20.1. France Oncaspar Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. France Oncaspar Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. France Oncaspar Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Oncaspar Market
21.1. Eastern Europe Oncaspar Market Overview
21.2. Eastern Europe Oncaspar Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Oncaspar Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Oncaspar Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. North America Oncaspar Market
22.1. North America Oncaspar Market Overview
22.2. North America Oncaspar Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. North America Oncaspar Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.4. North America Oncaspar Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. USA Oncaspar Market
23.1. USA Oncaspar Market Overview
23.2. USA Oncaspar Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. USA Oncaspar Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. USA Oncaspar Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. Canada Oncaspar Market
24.1. Canada Oncaspar Market Overview
24.2. Canada Oncaspar Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. Canada Oncaspar Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. Canada Oncaspar Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. South America Oncaspar Market
25.1. South America Oncaspar Market Overview
25.2. South America Oncaspar Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. South America Oncaspar Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. South America Oncaspar Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. Middle East Oncaspar Market
26.1. Middle East Oncaspar Market Overview
26.2. Middle East Oncaspar Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. Middle East Oncaspar Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. Middle East Oncaspar Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Africa Oncaspar Market
27.1. Africa Oncaspar Market Overview
27.2. Africa Oncaspar Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Africa Oncaspar Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.4. Africa Oncaspar Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Oncaspar Market Competitive Landscape And Company Profiles
28.1. Oncaspar Market Competitive Landscape
28.2. Oncaspar Market Company Profiles
28.2.1. Servier Pharmaceuticals LLC Overview, Products and Services, Strategy and Financial Analysis
29. Global Oncaspar Market Pipeline Analysis
29.1. High Level Clinic Trail Information
30. Global Oncaspar Market Competitive Benchmarking And Dashboard
31. Key Mergers And Acquisitions In The Oncaspar Market
32. Recent Developments In The Oncaspar Market
33. Oncaspar Market High Potential Countries, Segments and Strategies
33.1 Oncaspar Market In 2029 - Countries Offering Most New Opportunities
33.2 Oncaspar Market In 2029 - Segments Offering Most New Opportunities
